Details

Autor(en) / Beteiligte

• Ridde, Valéry
• Gautier, Lara
• Dagenais, Christian
• Chabrol, Fanny
• Hou, Renyou
• Bonnet, Emmanuel
• David, Pierre-Marie
• Cloos, Patrick
• Duhoux, Arnaud
• Lucet, Jean-Christophe
• Traverson, Lola
• de Araujo Oliveira, Sydia Rosana
• Cazarin, Gisele
• Peiffer-Smadja, Nathan
• Touré, Laurence
• Coulibaly, Abdourahmane
• Honda, Ayako
• Noda, Shinichiro
• Tamura, Toyomitsu
• Baba, Hiroko
• Kodoi, Haruka
• Zinszer, Kate

Titel

Learning from public health and hospital resilience to the SARS-CoV-2 pandemic: protocol for a multiple case study (Brazil, Canada, China, France, Japan, and Mali)

Ist Teil von

• Health research policy and systems, 2021-05, Vol.19 (1), p.76-76, Article 76

Ort / Verlag

England: BioMed Central Ltd

Erscheinungsjahr

2021

Link zum Volltext

Quelle

PAIS Index

Beschreibungen/Notizen

• All prevention efforts currently being implemented for COVID-19 are aimed at reducing the burden on strained health systems and human resources. There has been little research conducted to understand how SARS-CoV-2 has affected health care systems and professionals in terms of their work. Finding effective ways to share the knowledge and insight between countries, including lessons learned, is paramount to the international containment and management of the COVID-19 pandemic. The aim of this project is to compare the pandemic response to COVID-19 in Brazil, Canada, China, France, Japan, and Mali. This comparison will be used to identify strengths and weaknesses in the response, including challenges for health professionals and health systems. We will use a multiple case study approach with multiple levels of nested analysis. We have chosen these countries as they represent different continents and different stages of the pandemic. We will focus on several major hospitals and two public health interventions (contact tracing and testing). It will employ a multidisciplinary research approach that will use qualitative data through observations, document analysis, and interviews, as well as quantitative data based on disease surveillance data and other publicly available data. Given that the methodological approaches of the project will be largely qualitative, the ethical risks are minimal. For the quantitative component, the data being used will be made publicly available. We will deliver lessons learned based on a rigorous process and on strong evidence to enable operational-level insight for national and international stakeholders.